Mice with genetic ablation of Angptl6 exhibited greater obesity phenotypes, with increased hepatic fat accumulation and insulin resistance, in conjunction with impaired energy utilization [133], while Angptl6 overexpression improved hepatic steatosis and obesity under increased energy expenditure [133]. Here, ANGPTL6 is linked to obesity disorder.